FDA announced a Public Advisory Committee Meeting

FDA announced a Public Advisory Committee Meeting to review the approval of flibanserin for hypoactive sexual desire disorder (HSDD) in women on June 4, 2015. Should you wish to submit your written comments or request time at the public microphone, the deadline is a week away. Please find all details in the Federal Register Notice by clicking on this link. - -


Response to Op Ed Piece "Nothing Is Wrong WIth Your Sex Drive"

Letter from ISSWSH, as response to Op Ed Piece "Nothing Is Wrong WIth Your Sex Drive" in the NY Times.
Click here for the letter. - -

Information about the ISSWSH Business Meeting

The ISSWSH Business Meeting will take place in the Capitol Ballroom A-D of the Sheraton Austin Hotel at the Capitol in Austin, TX on Friday February 20, 2015. The meeting is scheduled for 60 minutes from 5:00 - 6:00 pm.

Letter from ISSWSH President, Dr. Parish, as response to an Op Ed piece in the LA Times

Click here for the letter. - -

Save The Date

ISSWSH Genitopelvic Pain Course 2022-2023

Multiple Dates
Virtual
Visit the Course Website

ISSWSH Annual Meeting 2023

March 2-5, 2023   88 days left
Marriott St. Louis Grand - St. Louis, MO
Visit the Meeting Website

ISSWSH Fall Course 2023

October 19-22, 2023   319 days left
DoubleTree Resort - Paradise Valley - Scottsdale, AZ
Visit the Course Website

ISSWSH Annual Meeting 2024

February 22-25, 2024   445 days left
Hyatt Regency Long Beach - Long Beach, CA
Visit the Meeting Website

Latest Tweets

There are two days left to submit your abstracts to the 2023 ISSWSH Annual Meeting in St. Louis, MO! Submit now:… https://t.co/vhrXyybw8v ISSWSH
Don't forget! The abstract deadline has been extended for the 2023 ISSWSH Annual Meeting in St. Louis. Submit by ne… https://t.co/H34Rl76Syv ISSWSH
Study finds that women are asked less frequently than men about Sexual Function After Brachytherapy https://t.co/K06GVCTrCw ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow Us

On Twitter
On Facebook
On Instagram